Advertisement
Home Blog Page 1699
For patients with low-grade upper tract urothelial cancer

UGN-101 Active in Chemoablation of Upper Tract Urothelial Cancer

0
Fifty-nine percent of patients had complete response at four to six weeks after initial therapy
A novel rifabutin-based triple therapy is effective for eradication of Helicobacter pylori

RHB-105 Effective for Eradication of Helicobacter pylori in Adults

0
Eradication rates with triple therapy unaffected by resistance to clarithromycin, metronidazole
The New York State Department of Health issued an advisory on May 6 regarding cases of pediatric multisystem inflammatory syndrome potentially associated with COVID-19.

New York State Reports Cases of Pediatric Inflammatory Syndrome Tied to COVID-19

0
Pediatric patients presenting with compatible symptoms should undergo SARS-CoV-2 testing
Yoga plus medical care is better than medical therapy alone for the treatment of episodic migraines

Yoga + Medical Care Better for Episodic Migraines

0
Improvement seen in headache frequency, intensity, pill count, disability assessments
Health care workers and younger people have an increased risk for a psychological impact from COVID-19

Health Care Workers at Risk From Mental Burden of COVID-19

0
Prevalence of anxiety symptoms higher for health care workers/young spending more time on outbreak
Human trials on an experimental COVID-19 vaccine began in the United States on Monday

Human Trials of Experimental COVID-19 Vaccine Begin in U.S.

0
If effective, vaccine could be available for emergency use in the United States as early as September
The presence of obesity

Teen Obesity, T2DM, HTN May Lead to Early Vascular Aging

0
Obesity, type 2 diabetes, elevated SBP accelerate progression of risk factors for vascular aging
For patients with COVID-19 and type 2 diabetes

Well-Controlled Blood Glucose May Improve COVID-19 Outcomes

0
Mortality lower in hospitalized COVID-19 patients with T2DM who had well-controlled blood glucose
The clinical burden associated with nonalcoholic fatty liver disease is high

High Clinical Burden Associated With Nonalcoholic Fatty Liver Disease

0
Prevalence of NAFLD was 5.7 percent, with cumulative risk for mortality of 12.6 percent for NAFLD
In an evidence-based guideline developed by an international team of physicians

Guideline Issued for Nonsevere, Severe COVID-19 Therapy

0
Corticosteroids recommended for severe COVID-19 with ARDS but not severe COVID-19 without ARDS